[Federal Register Volume 87, Number 117 (Friday, June 17, 2022)]
[Notices]
[Page 36460]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-13065]


-----------------------------------------------------------------------

DEPARTMENT OF COMMERCE

Foreign-Trade Zones Board

[B-04-2022]


Foreign-Trade Zone (FTZ) 177--Evansville, Indiana; Authorization 
of Production Activity; AstraZeneca Pharmaceuticals, LP (Pharmaceutical 
Products); Mount Vernon, Indiana

    On February 14, 2022, AstraZeneca Pharmaceuticals, LP submitted a 
notification of proposed production activity to the FTZ Board for its 
facility within FTZ Subzone 177A, in Mount Vernon, Indiana.
    The notification was processed in accordance with the regulations 
of the FTZ Board (15 CFR part 400), including notice in the Federal 
Register inviting public comment (87 FR 10332-10333, February 24, 
2022). On June 14, 2022, the applicant was notified of the FTZ Board's 
decision that no further review of the activity is warranted at this 
time. The production activity described in the notification was 
authorized, subject to the FTZ Act and the FTZ Board's regulations, 
including Section 400.14.

    Dated: June 14, 2022.
Andrew McGilvray,
Executive Secretary.
[FR Doc. 2022-13065 Filed 6-16-22; 8:45 am]
BILLING CODE 3510-DS-P